The global photobiomodulation market is estimated to be valued a USD 254.3 Mn in 2025 and is expected to reach USD 508.6 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 10.4% from 2025 to 2032. The rising prevalence of chronic diseases and increasing adoption of non-invasive procedures are expected to drive demand over the forecast period.
To learn more about this report, Request sample copy
The market is witnessing positive trends with the growing application scope for photobiomodulation therapy. It is increasingly being used in therapeutic areas like wound healing, pain management, and aesthetic treatment. Furthermore, clinical validation and approval for new indications will expand the market potential. Portable and affordable devices are also gaining interest among both patients and healthcare providers.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients